At a time when technology rules, radiologists can be early adopters of this philosophy to deliver better care to their patients.
In our new era, we need to change a lot to make healthcare work. I am a big proponent of patient activism and believe that patients need to take greater role in their own care.
At a time when technology rules, radiologists can be early adopters of this philosophy to deliver better care to their patients, who are also their customers.
For example, patients increasingly would like to know their imaging results. Consults with patients are not historically something we do. But could they be? Patients might also want to see relevant images or receive reports on their phones or iPads or even just know that the report is completed and available.
Data security is certainly still important but within that context, we should aim to provide the customer with what they want. Greater involvement in their own care can lead to better care and awareness for patients.
Sure there can be some confusion, and you must be prepared for that. But that is a straw-man argument for not doing this, as compared to a reduction in healthcare oversights and an increase in patient empowerment.
Likewise our other customers, referring physicians, may want similar service. With tagged images, text messaging and emails, and sharing sites like Google+, more and more referring providers want their info delivered seamlessly, quickly and electronically.
Further the seamless delivery of information across multiple platforms will be a necessity in the future when radiologists will be part of Accountable Care Organizations and integrated delivery models. We need to be an active part of the development of this infrastructure, and not on the sidelines.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.